← Full evidence page

For the cleanest result, disable browser headers and footers.

Dediabetes Evidence Brief

Post-Meal and OGTT Glucose

Evidence related to Post-Meal and OGTT Glucose.

Brief accessed
—

Full evidence pagehttps://www.dediabetes.com/evidence/post-meal-ogtt-glucose

Executive Summary

Post-Meal and OGTT Glucose evidence appears to center on Metformin.

Among 111 indexed studies and 87 interventions, the strongest signals are summarized from the available evidence. Low-carbohydrate diet has been studied often, while Metformin appears to have stronger current evidence signals.

  • Evidence is consistently positive across multiple studies.
  • Some evidence is positive, but results are not consistent across all studies.
  • Early findings are encouraging, but stronger trials are needed.

Caution

This summary reflects the currently indexed evidence and should not be interpreted as treatment advice.

Evidence Snapshot

Studies analyzed
111
Evidence relationships
100
Interventions
87
Outcomes
4
Strong evidence signals
7
Mixed evidence areas
4

Key Findings

  1. 01

    Across 6 studies, Metformin shows a consistent moderate positive signal for Glucose iAUC (OGTT).

  2. 02

    Across 5 studies, Lifestyle intervention for prediabetes shows a evidence signal for 2-hour plasma glucose.

  3. 03

    Across 4 studies, Low-carbohydrate diet shows a moderate positive signal for 2-hour plasma glucose.

  4. 04

    Across 4 studies, Insulin therapy shows a moderate positive signal for Glucose iAUC (OGTT).

Question Highlights

Which interventions have evidence for post-meal and ogtt glucose?

Metformin, Lifestyle intervention for prediabetes, and Insulin therapy are among the most studied approaches for post-meal and ogtt glucose.

Metformin, Lifestyle intervention for prediabetes, and Low-carbohydrate diet are among the best-supported options in the available evidence across 111 studies.

The evidence includes both beneficial and harmful or worsening results.

Read the full answer

Does Metformin improve glucose iauc (OGTT)?

Metformin may improve glucose iauc (OGTT).

Strong evidence is based on 6 supporting studies.

The evidence includes both beneficial and harmful or worsening results.

Read the full answer

Metformin vs Lifestyle intervention for prediabetes for post-meal and ogtt glucose?

Metformin and Lifestyle intervention for prediabetes have available evidence for post-meal and ogtt glucose, but the comparison requires review of the underlying studies.

Evidence is available for both Lifestyle intervention for prediabetes and Metformin; the underlying studies are needed for a direct comparison.

The evidence includes both beneficial and harmful or worsening results.

Read the full answer

Evidence Categories

The evidence is organized by how consistently it supports a conclusion and how much research is available.

Well-Supported Interventions

The strongest and most consistent evidence for improving this outcome.

Evidence is consistently positive across multiple studies.

Why it matters

Consistent positive findings are easier to interpret than isolated or mixed results.

Interpretation

Metformin appears to have a consistent beneficial signal in the indexed evidence.

Leading examples

Metformin · whey protein 20g · Lifestyle intervention for prediabetes

Evidence basis: 6 evidence pairs - 20 studies

Findings Requiring Careful Interpretation

Results that vary across studies or depend on population, study design, duration, or comparator.

Some evidence is positive, but results are not consistent across all studies.

Why it matters

Mixed results suggest effects may depend on population, comparator, duration, or study design.

Interpretation

Low-carbohydrate diet is mixed in the currently indexed evidence.

Caution

Some supporting studies reported neutral, negative, or mixed findings.

Leading examples

Low-carbohydrate diet · Metformin · Lifestyle intervention for prediabetes

Evidence basis: 8 evidence pairs - 26 studies

Emerging Areas of Research

Early positive signals that require additional high-quality research.

Early findings are encouraging, but stronger trials are needed.

Why it matters

Promising signals can guide further review, but they should not be treated as settled evidence.

Interpretation

Insulin therapy may have a beneficial signal, but the evidence base is still developing.

Caution

Current support is limited by study volume, RCT depth, or evidence strength.

Leading examples

Insulin therapy · whey protein 20g · Continuous glucose monitoring

Evidence basis: 8 evidence pairs - 16 studies

About this Evidence Brief

This brief summarizes research currently indexed by Dediabetes Evidence Intelligence. It is not a clinical guideline or personalized medical recommendation. Evidence classifications may change as additional studies are indexed.

Suggested citation

—